New Ebola Vaccine to Begin Human Trials in the UK

A new vaccine targeting the strain of Ebola currently spreading in the Democratic Republic of Congo is set to begin human trials in the UK, under plans announced today. The trials will test the vaccine on adults and represent the first clinical study of this particular candidate. The move responds to growing concern about the DRC outbreak.